{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:59:12Z","timestamp":1761101952211},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T00:00:00Z","timestamp":1301443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00296-011-1848-4","type":"journal-article","created":{"date-parts":[[2011,3,29]],"date-time":"2011-03-29T05:20:26Z","timestamp":1301376026000},"page":"1437-1441","source":"Crossref","is-referenced-by-count":5,"title":["Possible anti-metastatic effect of Iloprost in a patient with systemic sclerosis with lung cancer: a case study"],"prefix":"10.1007","volume":"32","author":[{"given":"Yavuz","family":"Pehlivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Halil","family":"Turkbeyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Balakan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"Sevinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Bakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,30]]},"reference":[{"key":"1848_CR1","first-page":"1979","volume-title":"Harrison principles of internal medicine","author":"BC Gilliland","year":"2005","unstructured":"Gilliland BC (2005) Systemic sclerosis and related disorders. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds) Harrison principles of internal medicine, 6th edn. New York, Mc Graw-Hill, pp 1979\u20131990","edition":"6"},{"key":"1848_CR2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.1780360405","volume":"36","author":"M Abu-Shakra","year":"1993","unstructured":"Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460\u2013464","journal-title":"Arthritis Rheum"},{"key":"1848_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00296-001-0141-3","volume":"21","author":"Y Yang","year":"2001","unstructured":"Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T (2001) Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 21:106\u2013111","journal-title":"Rheumatol Int"},{"key":"1848_CR4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00003495-200464070-00009","volume":"64","author":"DR Goldsmith","year":"2004","unstructured":"Goldsmith DR, Wagstaff A (2004) Inhaled iloprost in primary pulmonary hypertension. Drugs 64:763\u2013773","journal-title":"Drugs"},{"key":"1848_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1742-1241.1990.tb10799.x","volume":"44","author":"JP Scott","year":"1990","unstructured":"Scott JP, Higenbottam T, Wallwork J (1990) The acute effect of synthetic prostacyclin analogue iloprost in primary pulmonary hypertension. Br J Clin Pract 44:231\u2013234","journal-title":"Br J Clin Pract"},{"key":"1848_CR6","first-page":"119","volume":"29","author":"CM Black","year":"1995","unstructured":"Black CM (1995) The aetiopathogenesis of systemic sclerosis: thick skin-thin hypotheses. The parkes weber lecture. J R Coll Physicians Lond 29:119\u2013130","journal-title":"J R Coll Physicians Lond"},{"key":"1848_CR7","doi-asserted-by":"crossref","unstructured":"Siau K, Laversuch CJ, Creamer P, O\u2019Rourke KP (2010) Malignancy in scleroderma patients from south west England: a population-based cohort study. Rheumatol Int. 8. [Epub ahead of print]","DOI":"10.1007\/s00296-009-1348-y"},{"key":"1848_CR8","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/art.21225","volume":"52","author":"S Chatterjee","year":"2005","unstructured":"Chatterjee S, Dombi GW, Severson RK, Mayes MD (2005) Risk of malignancy in scleroderma. A population-based cohort study. Arthritis Rheum 52:2415\u20132424","journal-title":"Arthritis Rheum"},{"key":"1848_CR9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/263663a0","volume":"263","author":"S Moncada","year":"1976","unstructured":"Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663\u2013665","journal-title":"Nature"},{"key":"1848_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-71499-3_12","volume-title":"Prostacyclin and its stable analogue iloprost","author":"JJ Belch","year":"1987","unstructured":"Belch JJ (1987) Effect of iloprost (ZK 36374) on white cell behaviour. In: Gryglewski RJ, Stock G (eds) Prostacyclin and its stable analogue iloprost. Springer-Verlang, Berlin- Heidelberg, pp 97\u2013102"},{"key":"1848_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-71499-3_4","volume-title":"Prostacyclin and its stable analogue iloprost","author":"CS St\u00fcrzebecher","year":"1987","unstructured":"St\u00fcrzebecher CS (1987) Effects of iloprost on platelet activation in vitro. In: Gryglewski RJ, Stock G (eds) Prostacyclin and its stable analogue iloprost. Springer, Berlin-Heidelberg, pp 39\u201345"},{"key":"1848_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","volume":"120","author":"FM Wigley","year":"1994","unstructured":"Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA Jr, Steen VD, Varga J, Jimenes S, Mayes M (1994) Inrtavenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sklerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 120:199\u2013206","journal-title":"Ann Intern Med"},{"key":"1848_CR13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00047657","volume":"3","author":"GJ Gasic","year":"1984","unstructured":"Gasic GJ (1984) Role of plasma, platelets and endothelial cells in tumour metastasis. Cancer Metastasis Rev 3:99\u2013116","journal-title":"Cancer Metastasis Rev"},{"key":"1848_CR14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1126\/science.7015512","volume":"212","author":"KV Honn","year":"1981","unstructured":"Honn KV, Cicone B, Skoff A (1981) Prostacyclin: a potent antimetastatic agent. Science 212:1270\u20131272","journal-title":"Science"},{"key":"1848_CR15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF01753677","volume":"7","author":"G Sava","year":"1989","unstructured":"Sava G, Perisin L, Zorzet S, Piccini P, Giraldi T (1989) Antimetastatic action of the prostacyclin anologue Iloprost in the Mouse. Clinical and Experimental Meastasis 7:671\u2013678","journal-title":"Clinical and Experimental Meastasis"},{"key":"1848_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0090-6980(91)90036-F","volume":"42","author":"M Schirner","year":"1991","unstructured":"Schirner M, Schneider MR (1991) Cicaprost inhibits metastases of animal tumours. Prostaglandins 42:451\u2013461","journal-title":"Prostaglandins"},{"key":"1848_CR17","first-page":"450","volume":"44","author":"DG Menter","year":"1984","unstructured":"Menter DG, Onoda JM, Taylor JD, Honn KV (1984) Effect of prostacyclin on tumour cell-induced platelet aggregation. Cancer Res 44:450\u2013456","journal-title":"Cancer Res"},{"key":"1848_CR18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.2910600325","volume":"60","author":"DG Tang","year":"1995","unstructured":"Tang DG, Grossi IM, Tang KQ, Diglio CA, Honn KV (1995) Inhibition of TPA and 12(S)-HETE-stimulated tumour cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects. Int J Cancer 60:418\u2013425","journal-title":"Int J Cancer"},{"key":"1848_CR19","first-page":"901","volume":"21","author":"MR Schneider","year":"1991","unstructured":"Schneider MR, Schillinger E, Schirner M, Skuballa W, St\u00fcrzebecher S, Witt W (1991) Effects of prostacyclin analogues in in vivo tumour models. Adv Prostaglandin Thromboxane Leukot Res 21:901\u2013908","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-1848-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1848-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T23:06:33Z","timestamp":1686006393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-1848-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,30]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1848"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-1848-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,30]]}}}